Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Radojewski

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Therapeutic Advances in Neurological Disorders|March 27, 2024
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse eventsPauline Thränhardt, Admirim Veselaj, Christoph Friedli, et al.
Neuroimage. Clinical|December 13, 2023
Cerebral blood flow and white matter alterations in adults with phenylketonuriaLeonie Steiner, Raphaela Muri, Dilmini Wijesinghe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2018
MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid CancerOussama ElMokh, Vincent Taelman, Piotr Radojewski, et al.
Brain : a Journal of Neurology|May 9, 2024
Transient brain structure changes after high phenylalanine exposure in adults with phenylketonuriaRaphaela Muri, Christian Rummel, Richard McKinley, et al.
Magnetic Resonance in Medicine|December 23, 2024
ORACLE: An analytical approach for T<sub>1</sub>, T<sub>2</sub>, proton density, and off-resonance mapping with phase-cycled balanced steady-state free precessionNils M J Plähn, Yasaman Safarkhanlo, Berk C Açikgöz, et al.
Neuro-Degenerative Diseases|November 12, 2025
Clinical practice recommendations of the Swiss Society for Neuroradiology*: Neuroimaging standards for enrollment and disease monitoring in Anti-Amyloid ImmunotherapiesRoland Wiest, Piotr Radojewski, Johanna Maria Lieb, et al.
Brain Communications|June 2, 2023
Compromised white matter is related to lower cognitive performance in adults with phenylketonuriaRaphaela Muri, Stephanie Maissen-Abgottspon, Murray Bruce Reed, et al.
JAMA Oncology|February 15, 2019
Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysisReto M Kaderli, Marko Spanjol, Attila Kollár, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic IssuesMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine TumorsMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Neurological Disorders|March 27, 2024
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse eventsPauline Thränhardt, Admirim Veselaj, Christoph Friedli, et al.
Neuroimage. Clinical|December 13, 2023
Cerebral blood flow and white matter alterations in adults with phenylketonuriaLeonie Steiner, Raphaela Muri, Dilmini Wijesinghe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2018
MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid CancerOussama ElMokh, Vincent Taelman, Piotr Radojewski, et al.
Brain : a Journal of Neurology|May 9, 2024
Transient brain structure changes after high phenylalanine exposure in adults with phenylketonuriaRaphaela Muri, Christian Rummel, Richard McKinley, et al.
Magnetic Resonance in Medicine|December 23, 2024
ORACLE: An analytical approach for T<sub>1</sub>, T<sub>2</sub>, proton density, and off-resonance mapping with phase-cycled balanced steady-state free precessionNils M J Plähn, Yasaman Safarkhanlo, Berk C Açikgöz, et al.
Neuro-Degenerative Diseases|November 12, 2025
Clinical practice recommendations of the Swiss Society for Neuroradiology*: Neuroimaging standards for enrollment and disease monitoring in Anti-Amyloid ImmunotherapiesRoland Wiest, Piotr Radojewski, Johanna Maria Lieb, et al.
Brain Communications|June 2, 2023
Compromised white matter is related to lower cognitive performance in adults with phenylketonuriaRaphaela Muri, Stephanie Maissen-Abgottspon, Murray Bruce Reed, et al.
JAMA Oncology|February 15, 2019
Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysisReto M Kaderli, Marko Spanjol, Attila Kollár, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic IssuesMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine TumorsMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Pageof 6